TABLE 1

Effect of genetic variations, age, and gender on UGT2B17 protein abundance and activity

Glucuronide Formation Activity (pmol/min per mg of Microsomal Protein)
Protein Abundance (pmol/mg of Microsomal Protein)T-GlucuronideDHT-Glucuronide
nMeanMedianRange (Min–Max, Fold Difference)No. of <LOD SamplesnMeanMedianRange (Min-Max, Fold Difference)nMeanMedianRange (Min–Max, Fold Difference)
All samplesa3700.920.060.06–9.7, 16220232515.46.40.3–184, 55832541.826.21.0–233, 233
CN = 05300465.83.70.6–20.5, 344627.821.22.6–90.2, 35
CN = 11720.670.060.06–6.5, 10810713313.86.20.3–73.6, 22313340.827.41.0–165, 165
CN = 21981.140.190.06–9.7, 1629514619.97.80.5–184, 3681464729.51.5–233, 155
Diplotypes
Reference CAGA/CAGA1310.570.060.06–7.9, 132949113.85.70.5–123, 2469138.725.32.1–181.4, 86.4
Heterozygous TCAA/CAGG621.591.040.06–6.02, 100153527.521.40.5–98.2, 1963563.458.81.5–160, 107
Homozygous TCAG/TCAG581.631.030.06–9.7, 162113130.323.21.9–184, 96.83166578.3–233, 28
Age categories
 Neonatal30.060.060.06–0.06331.10.940.4–2.0, 534.83.81.6–9.0, 5.6
 Infancy230.110.060.06–0.86, 14.320193.31.30.4–11.5, 291914.16.21.0–55.1, 55.1
 Early childhood380.130.060.06–1.19, 2134296.63.70.3–33.1, 1102924.817.01.0–101, 101
 Middle childhood440.150.060.06–1.49, 24.834356.03.70.7–38.9, 563525.016.92.6–116, 44.6
 Adolescence610.810.060.06–6.9, 115335418.87.90.5–131.3, 2635448.532.12.1–194, 92
 Adulthood1851.330.460.06–9.7, 1627612723.212.60.8–185.8, 23212756.347.43.0–235, 78.3
Gender (age 12 yr)
 Male1491.600.910.06–9.7, 1626010826.918.10.5–184, 36810860.347.62.1–232, 110
 Female960.570.060.06–5.5, 92497313.99.20.79–98, 1247343.336.22.9–160, 55
  • a The samples with zero copy number were excluded from the analysis in all categories except the second row. Thirty-two samples (of 455) were excluded from these analyses because copy number (CN) variation data were not available on these samples.